Platte River Capital’s Pfizer PFE Stock Holding History

Platte River Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-81,790	Closed	-$2.6M	–	139
2015 Q2	$2.6M	Hold	81,790	–	–	1.31%	20
2015 Q1	$2.7M	Sell	81,790 -8,432	-9%	-$268K	1.21%	25
2014 Q4	$2.67M	Sell	90,222 -45,180	-33%	-$1.3M	0.99%	33
2014 Q3	$3.8M	Sell	135,402 -193,040	-59%	-$5.42M	0.98%	34
2014 Q2	$9.25M	Sell	328,442 -109,643	-25%	-$3.13M	1.4%	13
2014 Q1	$13.3M	Sell	438,085 -7,557	-2%	-$225K	1.81%	6
2013 Q4	$13M	Sell	445,642 -94,928	-18%	-$2.76M	1.66%	7
2013 Q3	$14.7M	Sell	540,570 -33,322	-6%	-$907K	1.82%	7
2013 Q2	$15.3M	Buy	+573,892	New	+$15.9M	1.78%	8

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Platte River Capital's PFE Position: Q3 2015 in Review

Platte River Capital sold out of Pfizer (PFE) in Q3 2015, closing a stake of 81,790 shares — an estimated $2.6M sold.

Platte River Capital first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $15.3M in Q2 2013. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Platte River Capital reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
Platte River Capital sold 81,790 Pfizer shares in Q3 2015, an estimated $2.6M.
Platte River Capital first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
Platte River Capital's Pfizer position peaked at $15.3M in Q2 2013.
1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.